1. Li, Heng, Liu, Yao, Cheng, Can, Wang, Jia-Bei, Liu, Lian-Xin. 2023. UBE2O reduces the effectiveness of interferon-α via degradation of IFIT3 in hepatocellular carcinoma. In Cell death & disease, 14, 854. doi:10.1038/s41419-023-06369-9. https://pubmed.ncbi.nlm.nih.gov/38129382/
2. Lin, Jiewei, Wang, Xinjing, Zhai, Shuyu, Wang, Jiancheng, Shen, Baiyong. 2022. Hypoxia-induced exosomal circPDK1 promotes pancreatic cancer glycolysis via c-myc activation by modulating miR-628-3p/BPTF axis and degrading BIN1. In Journal of hematology & oncology, 15, 128. doi:10.1186/s13045-022-01348-7. https://pubmed.ncbi.nlm.nih.gov/36068586/
3. Nguyen, Anthony T, Prado, Miguel A, Schmidt, Paul J, Fleming, Mark D, Finley, Daniel. . UBE2O remodels the proteome during terminal erythroid differentiation. In Science (New York, N.Y.), 357, . doi:10.1126/science.aan0218. https://pubmed.ncbi.nlm.nih.gov/28774900/
4. Lan, Si-Yu, Ding, Yang, Wang, Chun, Kang, Hui, Chang, Ying. 2022. High Level of Ubiquitin Conjugate Enzyme E2O Indicates Poor Prognosis of Patients with Hepatocellular Carcinoma. In Current medical science, 43, 93-103. doi:10.1007/s11596-022-2609-1. https://pubmed.ncbi.nlm.nih.gov/36269535/
5. Cheng, Jing, Zheng, Huancheng, Liu, Chenyu, Xing, Zhenkai, Wu, Yili. . Age-Associated UBE2O Reduction Promotes Neuronal Death in Alzheimer's Disease. In Journal of Alzheimer's disease : JAD, 93, 1083-1093. doi:10.3233/JAD-221143. https://pubmed.ncbi.nlm.nih.gov/37182872/
6. Xu, Yujia, Zhang, Zubin, Li, Jie, Zeng, Yuanying, Mao, Xinliang. 2017. The ubiquitin-conjugating enzyme UBE2O modulates c-Maf stability and induces myeloma cell apoptosis. In Journal of hematology & oncology, 10, 132. doi:10.1186/s13045-017-0499-7. https://pubmed.ncbi.nlm.nih.gov/28673317/
7. Shi, Zhan, Liu, Runkun, Lu, Qiliang, Huang, Dongsheng, Xu, Qiuran. 2021. UBE2O promotes hepatocellular carcinoma cell proliferation and invasion by regulating the AMPKα2/mTOR pathway. In International journal of medical sciences, 18, 3749-3758. doi:10.7150/ijms.63220. https://pubmed.ncbi.nlm.nih.gov/34790050/
8. Zhang, Wei, Li, Yanmeng, Xu, Anjian, Ou, Xiaojuan, Jia, Jidong. 2022. Identification of novel non-HFE mutations in Chinese patients with hereditary hemochromatosis. In Orphanet journal of rare diseases, 17, 216. doi:10.1186/s13023-022-02349-y. https://pubmed.ncbi.nlm.nih.gov/35668470/
9. Chen, Suping, Yang, Jing, Zhang, Yang, Zhou, Liang, Xu, Guoqiang. 2018. Ubiquitin-conjugating enzyme UBE2O regulates cellular clock function by promoting the degradation of the transcription factor BMAL1. In The Journal of biological chemistry, 293, 11296-11309. doi:10.1074/jbc.RA117.001432. https://pubmed.ncbi.nlm.nih.gov/29871923/
10. Liu, Xu, Ma, Fei, Liu, Chunxiao, Fu, Yingqiang, Qian, Cheng. 2020. UBE2O promotes the proliferation, EMT and stemness properties of breast cancer cells through the UBE2O/AMPKα2/mTORC1-MYC positive feedback loop. In Cell death & disease, 11, 10. doi:10.1038/s41419-019-2194-9. https://pubmed.ncbi.nlm.nih.gov/31907353/